A. Rahman and F. Azra, “DOCKING SIMULATION OF 1,2,3-TRIAZOLO-INDOLE-2-CARBOXYLATE DERIVATIVES AS POTENTIAL HER2 INHIBITORS FOR BREAST CANCER THERAPY”, JC, vol. 8, no. 2, pp. 273–287, Sep. 2026.